Clinical Trial: Registry-based Randomized Clinical Trial of Moderate-intensity Statin vs. Individualized Cholesterol Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359105) titled 'Registry-based Randomized Clinical Trial of Moderate-intensity Statin vs. Individualized Cholesterol Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)' on Jan. 14.

Brief Summary: Statins are the cornerstone of cardiovascular disease (CVD) prevention through the lowering of low-density lipoprotein cholesterol (LDL-C). While the benefits of intensive LDL-C lowering are well-established for secondary prevention, evidence remains insufficient for primary prevention in the elderly-specifically for individuals aged 70 years or older with type 2 diabetes who have no prior history of atherosclerotic cardiovascular events....